Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 142

    1.

    Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.

    Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS.

    Br J Ophthalmol. 2006 Jul;90(7):869-74. Epub 2006 Apr 5.PMID: 16597666 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.

    Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS.

    Retina. 2008 Jan;28(1):85-93.PMID: 18185143 [PubMed - indexed for MEDLINE]Related articles

    3.

    Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.

    Chan WM, Lai TY, Lai RY, Liu DT, Lam DS.

    Ophthalmology. 2008 Oct;115(10):1756-65. Epub 2008 Jun 5.PMID: 18538401 [PubMed - indexed for MEDLINE]Related articles

    4.

    Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.

    Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ, Klancnik JM Jr, Aizman A.

    Retina. 2003 Jun;23(3):288-98.PMID: 12824827 [PubMed - indexed for MEDLINE]Related articles

    5.

    Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.

    Lai TY, Chan WM, Lam DS.

    Am J Ophthalmol. 2004 May;137(5):826-33.PMID: 15126146 [PubMed - indexed for MEDLINE]Related articles

    8.

    Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy.

    Tarantola RM, Law JC, Recchia FM, Sternberg P Jr, Agarwal A.

    Lasers Surg Med. 2008 Dec;40(10):671-5.PMID: 19065564 [PubMed - indexed for MEDLINE]Related articles

    9.

    Photodynamic therapy for chronic central serous chorioretinopathy.

    Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM.

    Retina. 2003 Dec;23(6):752-63.PMID: 14707823 [PubMed - indexed for MEDLINE]Related articles

    10.

    Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

    Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH.

    Ophthalmology. 2004 Aug;111(8):1576-84.PMID: 15288991 [PubMed - indexed for MEDLINE]Related articles

    11.

    Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation.

    Lo Giudice G, Gismondi M, De Belvis V, Cian R, Tavolato M, Galan A.

    Retina. 2009 Jul-Aug;29(7):949-55.PMID: 19584653 [PubMed - indexed for MEDLINE]Related articles

    12.

    Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy.

    Mauget-Faÿsse M, Quaranta-El Maftouhi M, De La Marnièrre E, Leys A.

    Eur J Ophthalmol. 2006 Sep-Oct;16(5):695-704.PMID: 17061220 [PubMed - indexed for MEDLINE]Related articles

    13.

    Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.

    Chan WM, Lam DS, Lai TY, Yuen KS, Liu DT, Chan CK, Chen WQ.

    Am J Ophthalmol. 2003 Nov;136(5):836-45.PMID: 14597034 [PubMed - indexed for MEDLINE]Related articles

    14.

    Evaluation of subretinal fluid absorption by optical coherence tomography in circumscribed choroidal hemangioma after photodynamic therapy with Verteporfin.

    Soucek P, Cihelková I.

    Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):109-14.PMID: 15159693 [PubMed - indexed for MEDLINE]Related articles

    15.

    Photodynamic therapy with verteporfin for retinal angiomatous proliferation.

    Boscia F, Parodi MB, Furino C, Reibaldi M, Sborgia C.

    Graefes Arch Clin Exp Ophthalmol. 2006 Oct;244(10):1224-32. Epub 2006 Mar 9.PMID: 16525824 [PubMed - indexed for MEDLINE]Related articles

    16.

    Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

    Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.

    Arch Ophthalmol. 1999 Sep;117(9):1177-87. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496389 [PubMed - indexed for MEDLINE]Related articles

    17.

    Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy.

    Kim SW, Oh J, Oh IK, Huh K.

    Ophthalmic Surg Lasers Imaging. 2009 May-Jun;40(3):300-3.PMID: 19485297 [PubMed - indexed for MEDLINE]Related articles

    18.

    Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy.

    Ober MD, Yannuzzi LA, Do DV, Spaide RF, Bressler NM, Jampol LM, Angelilli A, Eandi CM, Lyon AT.

    Ophthalmology. 2005 Dec;112(12):2088-94.PMID: 16325707 [PubMed - indexed for MEDLINE]Related articles

    19.

    Chronic central serous chorioretinopathy: photodynamic therapy.

    Taban M, Boyer DS, Thomas EL, Taban M.

    Am J Ophthalmol. 2004 Jun;137(6):1073-80.PMID: 15183792 [PubMed - indexed for MEDLINE]Related articles

    20.

    Supplemental Content

    Find related data